http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006116217-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b6121dedd894b3f760906b68697d616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75d0b73cf0a67027619ff05d2183eca2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
filingDate 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_915f040f3dc804ffc069f64bf21f24fe
publicationDate 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006116217-A3
titleOfInvention Therapeutic bifunctional compounds
abstract The invention generally relates to systems and methods for treating inflammatory and proliferative diseases, enabling treatment of MDR tumor cells by using a bifunctional compound that inhibits both fatty acid metabolism and glycolysis. Thus, the invention links a fatty acid metabolism inhibitor to a glycolysis inhibitor. More particularly, the invention provides novel bifunctional compounds that link a moiety having the functionality of an oxirane carboxylic acid compound to a moiety having the functionality a glucose derivative. In specific embodiments, the invention provides a bifunctional compound that links a moiety having the functionality of etomoxir to a moiety having the functionality of 2-deoxy-D-glucose.
priorityDate 2005-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0134145-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004111199-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413738604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13159185
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226432916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9840324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399014
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421144290

Total number of triples: 32.